(Q44496983)

3 December 2017

1 reference

title

Perspectives on diabetic retinopathy. (English)

1 reference

3 December 2017

Lloyd M Aiello

1

1 reference

3 December 2017

language of work or name

English

0 references

publication date

1 July 2003

1 reference

American Journal of Ophthalmology

3 December 2017

published in

1 reference

3 December 2017

volume

136

1 reference

3 December 2017

issue

1

1 reference

3 December 2017

page(s)

122-135

1 reference

Ruby laser photocoagulation of early diabetic neovascular retinopathy. Preliminary report of a long-term controlled study

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900219-8

Preliminary report on effects of photocoagulation therapy. The Diabetic Retinopathy Study Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900219-8

Photocoagulation Treatment of Proliferative Diabetic Retinopathy: The Second Report of Diabetic Retinopathy Study Findings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900219-8

Photocoagulation for Diabetic Macular Edema

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900219-8

Treatment techniques and clinical guidelines for photocoagulation of diabetic macular edema. Early Treatment Diabetic Retinopathy Study Report Number 2. Early Treatment Diabetic Retinopathy Study Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900219-8

Techniques for scatter and local photocoagulation treatment of diabetic retinopathy: Early Treatment Diabetic Retinopathy Study Report no. 3. The Early Treatment Diabetic Retinopathy Study Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900219-8

Photocoagulation for diabetic macular edema: Early Treatment Diabetic Retinopathy Study Report no. 4. The Early Treatment Diabetic Retinopathy Study Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900219-8

Case reports to accompany Early Treatment Diabetic Retinopathy Study Reports 3 and 4. The Early Treatment Diabetic Retinopathy Study Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900219-8

Detection of diabetic macular edema. Ophthalmoscopy versus photography--Early Treatment Diabetic Retinopathy Study Report Number 5. The ETDRS Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900219-8

Aspirin effects on mortality and morbidity in patients with diabetes mellitus. Early Treatment Diabetic Retinopathy Study report 14. ETDRS Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900219-8

Impaired color vision associated with diabetic retinopathy: Early Treatment Diabetic Retinopathy Study Report No. 15.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900219-8

Aspirin effects on the development of cataracts in patients with diabetes mellitus. Early treatment diabetic retinopathy study report 16

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900219-8

Pars plana vitrectomy in the Early Treatment Diabetic Retinopathy Study. ETDRS report number 17. The Early Treatment Diabetic Retinopathy Study Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900219-8

Effects of aspirin on vitreous/preretinal hemorrhage in patients with diabetes mellitus. Early Treatment Diabetic Retinopathy Study report no. 20.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900219-8

Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy. Early Treatment Diabetic Retinopathy Study (ETDRS) Report 22.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900219-8

Subretinal fibrosis in diabetic macular edema. ETDRS report 23. Early Treatment Diabetic Retinopathy Study Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900219-8

Causes of severe visual loss in the early treatment diabetic retinopathy study: ETDRS report no. 24. Early Treatment Diabetic Retinopathy Study Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900219-8

Results after lens extraction in patients with diabetic retinopathy: early treatment diabetic retinopathy study report number 25.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900219-8

Two-year course of visual acuity in severe proliferative diabetic retinopathy with conventional management. Diabetic Retinopathy Vitrectomy Study (DRVS) report #1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900219-8

Early vitrectomy for severe proliferative diabetic retinopathy in eyes with useful vision. Clinical application of results of a randomized trial--Diabetic Retinopathy Vitrectomy Study Report 4. The Diabetic Retinopathy Vitrectomy Study Research Grou

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900219-8

Early vitrectomy for severe proliferative diabetic retinopathy in eyes with useful vision. Results of a randomized trial--Diabetic Retinopathy Vitrectomy Study Report 3. The Diabetic Retinopathy Vitrectomy Study Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900219-8

Progression of retinopathy with intensive versus conventional treatment in the Diabetes Control and Complications Trial. Diabetes Control and Complications Trial Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900219-8

Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900219-8

Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900219-8

Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900219-8

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900219-8

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900219-8

Relationship between the severity of retinopathy and progression to photocoagulation in patients with Type 2 diabetes mellitus in the UKPDS (UKPDS 52)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900219-8

United Kingdom Prospective Diabetes Study, 30: diabetic retinopathy at diagnosis of non-insulin-dependent diabetes mellitus and associated risk factors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900219-8

Retinal Oxygenation and Laser Treatment in Patients With Diabetic Retinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900219-8

On the Pathogenesis of Diabetic Retinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900219-8

Distribution of Capillary Nonperfusion in Early-stage Diabetic Retinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900219-8

Midperipheral fundus involvement in diabetic retinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900219-8

The association of microalbuminuria with diabetic retinopathy. The Wisconsin Epidemiologic Study of Diabetic Retinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900219-8

Effect of pregnancy on progression of diabetic retinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900219-8

Diabetic retinopathy during pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900219-8

Metabolic control and progression of retinopathy. The Diabetes in Early Pregnancy Study. National Institute of Child Health and Human Development Diabetes in Early Pregnancy Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900219-8

Gastric emptying in diabetes: clinical significance and treatment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900219-8

High-dose vitamin E supplementation normalizes retinal blood flow and creatinine clearance in patients with type 1 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900219-8

Stereo nonmydriatic digital-video color retinal imaging compared with Early Treatment Diabetic Retinopathy Study seven standard field 35-mm stereo color photos for determining level of diabetic retinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900219-8

Use of Joslin Vision Network digital-video nonmydriatic retinal imaging to assess diabetic retinopathy in a clinical program

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900219-8

Vascular endothelial growth factor induces expression of connective tissue growth factor via KDR, Flt1, and phosphatidylinositol 3-kinase-akt-dependent pathways in retinal vascular cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900219-8

Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900219-8

Retinal vascular endothelial growth factor (VEGF) mRNA expression is altered in relation to neovascularization in oxygen induced retinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900219-8

Correlation of vascular permeability factor/vascular endothelial growth factor with extraretinal neovascularization in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900219-8

Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900219-8

Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900219-8

Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900219-8

Detection of vascular endothelial growth factor messenger RNA and vascular endothelial growth factor-like activity in proliferative diabetic retinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900219-8

Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900219-8

Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900219-8

Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900219-8

Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900219-8

Pigment epithelium-derived factor: a potent inhibitor of angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900219-8

Intravitreal triamcinolone for refractory diabetic macular edema

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900219-8

The effects of panretinal photocoagulation on dark adaptation in diabetics with proliferative retinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900219-8

Internal Ophthalmoplegia After Argon Laser Panretinal Photocoagulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900219-8

Role of vascular endothelial growth factor in diabetic vascular complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900219-8

Four risk factors for severe visual loss in diabetic retinopathy. The third report from the Diabetic Retinopathy Study. The Diabetic Retinopathy Study Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900219-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Early worsening of diabetic retinopathy in the Diabetes Control and Complications Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900219-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9394(03)00219-8

1 reference

3 December 2017

1 reference